Skip to content 
Six months on, what’s changed (and what hasn’t) for AI in research?
From experimentation to implementation, we share seven takeaways from our latest AI in market research roundtable, covering adoption, trust, synthetic respondents and AI moderation.
Synthetic data: What your CMO needs to know
STRAT7 tested synthetic data against real survey responses two years running. Accurate at the topline, unreliable beneath it. What insight leaders need to know before buying.
Synthetic data: What does my CMO need to know?
Sarah Askew and Hasdeep Sethi unpack STRAT7’s latest synthetic data study: what’s improved in a year, where it still fails, and what CMOs should do.
Synthetic data: Is this as good as it gets?
Want to know how synthetic data really performs? Which provider delivers the most accurate results? You need more than marketing claims. You need a side-by-side comparison, grounded in the same baseline data, tested across the same scenarios. That’s exactly what we did.
The market research capability gap that AI tools won’t fill
AI tools are now the easy part. The harder part is your team’s ability to evaluate them, integrate them, and advise the business on where they help and where they don’t.
AI in market research: Three case studies of what’s now possible
AI in market research is opening up work that wasn’t commercially viable before. Three real client projects through Nucleus show what’s now possible.
AI won’t replace your research team, it will change what they do
AI vendors promise faster, cheaper research. Insight leaders are still right to push back. The case for caution, and how to use AI in market research without losing rigour.
How the patient journey is about to be redrawn
AI will accelerate some patient journeys, stall others and reroute the rest. STRAT7 maps where the patient journey bends and two actions for pharma.
The AI-primed patient is already in the consultation room. Pharma needs to act now
The AI-primed patient is already in the consultation room. New STRAT7 data: 45.5% of consumers plan to use ChatGPT Health. Here’s what pharma should do now.
How generational attitudes are reshaping consumer expectations of financial brands
New STRAT7 research into what UK consumers across four generations – Gen Z, Millennials, Gen X and Boomers – now want from their financial provider.
